Additionally, research in rodents has reported that BDZs exacerbate AD progression by increasing tau protein phosphorylation, which consequently causes insulin resistance and compensatory overactivation of GABAergic neurons [91–93]. The gene discussed is MAPT; the disease is Alzheimer disease.